[url]https://www.covid-red.eu/en/[/url] or https://www.covid-red.eu/en/ - https://www.covid-red.eu/en/ ;COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.

DJ-Much more info on the site ! I think this fits in in long term planning. Improved monitoring, early detection of cases can also slow down the spread of Covid19 (variants). 

Objectives

In summary, the overall objectives of this project are:

1. To assess the diagnostic and prognostic value of monitoring vital signs (such as breathing rate, pulse rate, skin temperature, and heart rate variability) by bracelet in users at home (for early COVID-19 case identification).
2. To monitor individuals after the diagnosis to detect deterioration and that are under medical supervision (for early identification of COVID-19 patients requiring mechanical ventilation and/or intensive care) (WP 1)
3. To study the added value of these remotely measured vital signs to the patient reported outcomes (WP3)
4. To assess on the economic and clinical effects of monitoring vital signs for the early detection of COVID19 and in the detection of deterioration after the diagnosis (WP4)
5. To generate a large database on vital signs and symptoms over time, and health care usage, that can be linked to COVID-19 antibody presence (as a marker of past COVID-19 infection) at the end of the data collection period (WP2)
6. To deliver large open-source databases that are GDPR compliant (WP5)
7. To partner with stakeholders and other related projects to create a network and maximize project impact (WP6)
8. To ensure the efficient & effective management of the consortium and sustainability of results, in compliance with the Grant Agreement and Consortium Agreement. (WP7)